
Can mHealth and AI amp up tobacco cessation efforts?
28.6 % of the people aged 15 and above use tobacco in India, the use of smokeless forms being double that of smoked forms. This can be attributed to the social acceptability of smokeless tobacco (SLT), especially among women in old times. Tobacco continues to hold cultural value in local traditions, where it is offered to guests and gods with equal reverence.
The second largest consumer—and third largest producer—of tobacco, India is home to 72.7 million smokers. It is responsible for 13.5 lakh deaths, 1.5 lakh cancers, 4.2 million heart diseases, and 3.7 million lung diseases every year. With a 20 % share of the global burden load, India is touted as the oral cancer capital of the world.
Also Read | From tea stalls to tumours, tobacco affordability fuelling cancer epidemic in India
Secondhand smoking (SHS), caused by the inhalation of toxic fumes when somebody is smoking in the vicinity, compounds the problem further. It contributes to 14% of total tobacco deaths, with the brunt falling squarely on the most vulnerable—women, children, and older people. Almost half of the non-smoking women and over one-third of pregnant women are exposed to tobacco smoke in India and Bangladesh.
According to GATS 2, despite 85.6% of people being aware of the detrimental effects of SHS, 38.7% of people working at home and 30.2% working indoors were exposed to smoking. A 2023 report by WHO on global tobacco epidemic believes that physical distancing—whether it be designated smoke rooms (DSRs) or ventilation—fails to protect from the exposure of SHS.
The smoke residues from 7000 chemicals, including over 70 carcinogenic substances, cling to physical surfaces long after a cigarette is stubbed out. Through case studies of popular smoke ban laws in Atlanta and Finland, WHO FCTC's Section 8 advocates for strict legislation for a smoke-free environment to protect our basic right to breathe in clean air.
Also Read | Two decades after India's public smoking ban, challenges persist in tobacco control
Dependency on tobacco
Multiple studies have shown that dependence on tobacco and bidis significantly impairs individuals' ability to quit. The wide availability of locally-produced tobacco brands in India further complicates regulation of nicotine content. Moreover, Big Tobacco is frequently accused of deliberately maintaining high nicotine levels to promote addiction.
Furthermore, the tobacco industry lobbying has actively obscured critical information and deflected public discourse from the health risks linked to tobacco use. This has resulted in manufacturing of narratives, such as conflating the harms of tobacco smoking with air pollution. What harm will one cigarette cause when the level of pollution amounts to breathing 20 cigarettes a day!? (While air pollution demands urgent action, the harm caused by cigarette smoke is 2 to 2.5 times greater, according to a Chinese study.) In the 1996 issue of Time Magazine, the president and CEO of Philip Morris was quoted saying that cigarettes are no more addictive than coffee or gummy bears.
This impact on teenagers by Big Tobacco propaganda is concerning. 8.5% of young adolescents (between 13 and 15 years) consume tobacco in some form in India. With stylish names, flashy packaging, fancy brand ambassadors, and fun flavours, the tobacco industry preys on the young to initiate tobacco use as well as continue it. A WHO report highlighted the addition of sweetening agents, flavorings, bronchodilators, and additives such as levulinic acid and menthol to tobacco products—measures intended to reduce the harshness of nicotine and create a cooling effect in the throat. These modifications in taste, smell, and sensory appeal, experts believe, hype the demand of these products among the youth.
Kicking the habit
The GATS 2 survey revealed that out of the total people who wanted to quit, 70% had to do it alone, and most couldn't sustain it beyond a month. We must also realize that cessation is not a one-off thing but a continuum—the counselling must always be ongoing and adaptive. Pranav Ish, a pulmonologist at VMMC and Safdarjung Hospitals said even 2-3 minutes of reinforcement has worked wonders in his patients. GATS 2, however, reveals a dismal picture when it comes to the attitude of healthcare providers: only 31.7% of healthcare providers advised their patients to quit in the last month, and 48.8% in the last year.
Aninda Debnath, assistant professor, Community Medicine, MAMC, Delhi, says that while a lot of programs related to tobacco cessation are in place, a critical look at their functioning and utilisation is important. The COTPA Act prohibits advertising of tobacco in any form; however, a study by Vital Strategies found 75 % of online surrogate marketing of tobacco on Meta platforms.
Vikrant Mohanty, HoD and Project Head, National Resource Centre for Oral Health and Tobacco Cessation, MAIDS, Delhi, said: 'While the government is doing its bit through cessation services at primary level, dedicated counsellors in NCD clinics, dentist training under NOHP, a comprehensive approach with integration of stakeholders at various levels is the need of the hour. The dropout from follow-up still remains huge, and faith in the treatment low.'
Also Read | Smokeless tobacco products contribute to over 50% of oral cancer cases in India, study finds
AI to the rescue
Traditional forms of counseling are, for one, not equitable—the social desirability bias kicks in when hospitals expect the patient to come back. Plus, affordability and accessibility to TCCs is an issue for most who come from lower to lower-middle classes and work in informal sectors or as daily wage workers. Researchers have found that the results of tobacco cessation have stagnated, or at times gone down, for people with social disadvantage. While mCessation in the form of encouraging text messages or telephonic counselling through NTQLS has been an innovative solution (as part of WHO's Be He@lthy, Be mobile), limited success has been observed. Some of the gaps in successful implementation of mHealth include voice recognition inaccuracies, network connectivity issues, poor digital literacy, shoddy interface, absence of personal connection, poor long-term engagement, and high attrition rates. Integrating mHealth with innovative solutions such as PSD (Persuasive Systems Design) or just-in-time-adaptive-intervention (JITAI) that deliver an intervention in moments of elevated need or receptivity has shown great promise.
This is where AI can give us a leg up. Mohanty adds that large language models can bridge the gap of delivery, provide personalized healthcare systematically, capture data, and use them in improving the outcomes.'
AI can be harnessed not only through chatbots but also indirectly to train healthcare professionals so they can assess, advise and follow-up with the patients rigorously. Dr. Debanath emphasised the importance of refresher training—a component often neglected—which can be made significantly more accessible and efficient with the help of AI.'
Monika Arora, Vice President of Research and Health Promotion at PHFI, believes, 'Chatbots and virtual assistants powered by AI can provide round-the-clock support, track and monitor tobacco use behavior, offer evidence-based information, and deliver personalized motivational messages. AI can also utilize predictive analytics to identify individuals at higher risk of relapse and tailor interventions accordingly.'
However, this can't happen in isolation. All the interviewees believed that AI should not be thought of as an alternative but as an adjunct to traditional strategies. Dr. Arora and others are working on an AI-based model under Project CARE, where the focus is on 'co-development with users and healthcare providers' who can come up with innovative and contextually relevant solutions.
Also Read | The tobacco epidemic in India
Digital literacy challenge
However, all is not rosy with mHealth and AI. While mobile penetration in the country is good, the lack of digital literacy might act as a massive deterrent. Debnath shared a personal anecdote: 'My mother has a smartphone, but she uses it only for calling and WhatsApp.' Moreover, in this age of digital revolution, when we are always bombarded with text messages and the ubiquitous 'ting' of notifications, the impact of one more message needs to be looked at with a fair bit of skepticism.
These newer innovations should be complemented with other time-tested strategies. Plain packaging, which was initiated by Australia for the first time in 2012—and was followed by a wave of countries—should be considered as the next step to challenge the growing empire of tobacco corporations. Stronger warnings, higher taxes, increasing the size of graphic warnings, banning e-cigarettes, and hiring brand ambassadors cam aid our efforts.
Emerging approaches such as adaptive counseling, designed to provide stepped care that addresses patients' unmet needs and parallels chronic disease management, can also be considered. Dr. Ish added: 'It feels rewarding that a patient who could earlier smoke three cigarettes had to contend with only one due to high costs.'
India has garnered international attention for its tobacco cessation program, but the sheer burden of tobacco warrants that we not only explore newer strategies while also ensuring rigorous implementation of the existing ones.
(Kinshuk Gupta is a writer, journalist, and public health physician. His debut book is Yeh Dil Hai Ki Chor Darwaja. kinshuksameer@gmail.com)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
12 hours ago
- Time of India
India's new health push needs deeper inclusion
. In a country where nearly every rural household can access basic health infrastructure, one might assume the battle for public health equity is won. Yet, the numbers sober the story by a few notches: Only 65% of households consistently use improved health facilities, with even lower uptake among Scheduled Castes, Scheduled Tribes, and other marginalised groups. The paradox is clear. Bricks and mortar are in place, but trust, awareness, and access remain fragile. A 2024 scientific study based o n NFHS-5 data underscores this inequality. It found that wealthier households were dramatically more likely — up to 47 times in some cases — to access improved healthcare, even after adjusting for location and education. India's central and eastern regions continue to exhibit the starkest disparities, despite marginal improvement over past survey cycles. The socioeconomic gradient in healthcare access, in short, persists with quiet but deep severity. This divide is more than statistical. Research from urban slums in Kolkata and Bengaluru has shown that generations of deprivation can normalise poor health outcomes and reduce healthcare-seeking behaviour. As a result, even when clinics are built and services are free, utilisation lags unless interventions are grounded in community engagement and led by locally trusted actors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo . Here, international benchmarks offer both warning and inspiration. UN Sustainable Development Goal 3 calls for universal, equitable health access by 2030, yet UNICEF-WHO data reveals that only 52% of people globally have access to essential health services — and a staggering 70% still lack basic hygiene facilities at home. India mirrors this imbalance: patchy uptake, despite broader infrastructure. In this context, Corporate Social Responsibility (CSR) emerges not as a stopgap, but as a potential catalyst for lasting change. When rooted in community participation, equity, and sustainability, CSR-led health interventions can extend the state's reach and build social trust. Consider Vedanta's SEHAT initiative, which supports primary health centres (PHCs), conducts menstrual health and addiction awareness camps, and has reached over 11,000 rural patients in Punjab. Household healthcare spending in these areas has dropped by nearly 70%, according to internal assessments. Vedanta's Nand Ghar project, in partnership with the ICDS, leverages telemedicine and mobile health vans to provide maternal and child healthcare in over 6,300 anganwadi centres. The addition of solar-powered borewells and purifiers under Project Nirmal brings a layer of climate resilience. Similarly, Hyundai Motor India Foundation's Sparsh Sanjeevani network of 35 mobile and telemedicine units has served over 1.5 million people across seven states, including in high-altitude areas of Ladakh and Jammu & Kashmir. The NTPC Foundation invested Rs 254 crore in FY 2023–24 on health and water projects, impacting 1.6 million people across 581 villages. Other examples stand out for their focus on stigmabusting. Aditya Birla Education Trust's Ujaas initiative runs a mobile van that promotes menstrual hygiene awareness and distributes sanitary pads in collaboration with women-led selfhelp groups. Tata's Aarogyatara programme has enabled 65,000 cataract surgeries and distributed over 37,000 spectacles, targeting preventable blindness. On the prevention and education front, Wipro has strengthened hygiene education in schools, and Olympus Medical Systems India has supported ENT screenings and installed sanitation facilities in schools for over 2,700 children. What these initiatives share is not just funding, but a design philosophy: preventive orientation, vulnerable population targeting, system alignment, and sustainability. These are in line with WHO-UNICEF's 2025 guidelines, which stress rightsbased, locally embedded health delivery. The Times of India CSR (Corporate Social Responsibility) and ESG (Environmental, Social, and Governance)/Social Impact Summit 2025 is expected to provide a platform for further dialogue on gender inclusion.


Indian Express
a day ago
- Indian Express
WHO's ‘3 by 35' initiative targets tobacco, alcohol and sugary drinks
The World Health Organization (WHO) has launched a '3 by 35' initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50 per cent by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue. Led by WHO, the initiative brings together a group of global partners to help countries put health taxes into action. These organizations offer a mix of technical know-how, policy advice, and real-world experience. By working together, they aim to raise awareness about the benefits of health taxes and support efforts at the national level. As per WHO officials, the consumption of tobacco, alcohol, and sugary drinks are fueling the epidemic of non-communicable diseases. NCDs, including heart disease, cancer, and diabetes, account for over 75 per cent of all deaths worldwide. A recent report shows that a one-time 50 per cent price increase on these products could prevent 50 million premature deaths over the next 50 years. 'Health taxes are one of the most efficient tools we have,' Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO, said in an official statement. The initiative has an ambitious goal of raising US $1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50 per cent on average, showing that large-scale change is possible, according to the WHO report. Many countries have expressed interest in transitioning toward more self-reliant, domestically funded health systems and are turning to WHO for guidance. The '3 by 35' initiative introduces key action areas to help countries, pairing proven health policies with best practices on implementation. These include direct support for country-led reforms, mobilizing domestic public resources to fund essential health and development programmes, including universal health coverage. India has implemented tobacco taxation under the GST framework, with 28 per cent GST and an additional compensation cess on cigarettes and select products. However, bidis (smoked by low-income groups) and smokeless tobacco (SLT) (used by over two-thirds of tobacco users) remain under-taxed. Experts said that India's current approach to taxing tobacco, alcohol and sugar-sweetened beverages represents a fragmented, revenue-centric model that lacks a coherent public health framework. 'India's current taxation of tobacco, alcohol, and sugar-sweetened beverages represents substantial untapped potential for public health advancement. The absence of a coherent health tax framework limits their effectiveness in addressing India' s growing NCD burden. The WHO 3 by 35 Initiative provides both the rationale and the roadmap for transformation, offering a pathway to shift from revenue-driven to public health-oriented taxation that can achieve the dual objectives of sustainable health financing and disease prevention,' Dr Prashant Kumar Singh, senior scientist at Indian Council of Medical Research- National Institute of Cancer Prevention and Research told The Indian Express. Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More


Hindustan Times
a day ago
- Hindustan Times
Caution not anti-science, says CM as slugfest over vaccine heats up
A social media spat between chief minister Siddaramaiah and Biocon Executive chairperson Kiran Mazumdar-Shaw has brought renewed attention to the safety of COVID-19 vaccines and their possible long-term side effects. The exchange follows mounting concerns in Hassan district, where a spike in sudden heart-related deaths has raised public alarm. Caution not anti-science, says CM as slugfest over vaccine heats up The chief minister's initial remarks on July 1 questioned whether the deaths could be connected to the fast-tracked rollout of vaccines during the pandemic. While acknowledging that the vaccines were introduced under extraordinary global circumstances, Siddaramaiah suggested that the speed of approval may have overlooked long-term effects. 'It cannot be denied that the hasty approval and distribution of the COVID-19 vaccines to the public could also be a reason for these deaths,' he said in a post on the social media platform X, citing emerging global research linking vaccines to heart-related complications. To address public concerns, Siddaramaiah said his government had formed an expert committee led by Dr Ravindranath KS of Sri Jayadeva Institute of Cardiovascular Sciences and Research. The panel's mandate is to determine whether there is any scientific link between the vaccine rollout and the recent deaths in Hassan. In response, Shaw on Thursday challenged the chief minister's framing of the vaccine development process, calling it misleading and inaccurate. She said that India's vaccines were granted Emergency Use Authorisation (EUA) after meeting globally accepted safety and efficacy norms. 'To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation,' she wrote, while also noting that side effects, though rare, did occur with any vaccine. In her follow-up post, Shaw said she agreed with the need for investigations into sudden deaths but reiterated that the regulatory process followed for vaccine approval met international standards. 'My response was that due process was followed as prescribed by WHO for safety and efficacy for Emergency Use Authorisation,' she wrote. 'Losing lives in a sudden manner is always tragic, and I am glad an investigation is being conducted in Hassan district.' By Friday, the discussion intensified as Siddaramaiah returned to the issue, stating that his role as chief minister obligated him to respond to the distress of families who had lost loved ones. 'When parents lose their young children or families lose breadwinners without warning, seeking clarity is not misinformation; it is an act of governance rooted in empathy,' he said. The chief minister further argued that questioning vaccine safety should not be equated with denialism or anti-science sentiment. He referred to studies published in journals such as Nature, Circulation, and the Journal of the American College of Cardiology, which have examined risks like myocarditis and cardiac arrest among younger populations post-vaccination. He also cited an admission by AstraZeneca about rare but serious side effects. 'Scientific caution is not anti-science,' Siddaramaiah said, adding that 'publicly funded stakeholders must acknowledge both the benefits and the potential risks without fear or favour.' He clarified that his use of the term 'hastily' was in reference to the emergency rollout timelines that global health agencies, including the WHO, had termed a 'calculated risk' during the height of the pandemic. 'Haste is not a sin when saving lives,' he said, 'but acknowledging potential unintended consequences is wisdom.' Meanwhile, the Union health ministry dismissed any connection between COVID-19 vaccines and the recent deaths. Referring to data from the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC), the ministry asserted that the vaccines were both safe and effective, with serious adverse reactions being extremely rare.